Q3 2024 |
10 |
$97.3M |
+$3.85M |
$0 |
+$3.85M |
EWTX, ARVN, CRNX, RLYB, RCKT
|
13F-HR |
11/13/2024, 05:22 PM |
Q2 2024 |
10 |
$82.2M |
+$699K |
-$9.08M |
-$8.38M |
ARVN, EWTX, CRNX, RLYB, RCKT
|
13F-HR |
8/13/2024, 06:17 PM |
Q1 2024 |
11 |
$114M |
$0 |
-$21.1M |
-$21.1M |
ARVN, EWTX, DCPH, CRNX, RLYB
|
13F-HR |
5/14/2024, 04:19 PM |
Q4 2023 |
12 |
$124M |
+$17.5M |
-$11.7M |
+$5.87M |
ARVN, HARP, EWTX, DCPH, RLYB
|
13F-HR |
2/13/2024, 09:44 PM |
Q3 2023 |
12 |
$77.9M |
$0 |
-$29.9M |
-$29.9M |
ARVN, DCPH, RLYB, EWTX, COGT
|
13F-HR |
11/13/2023, 06:23 PM |
Q2 2023 |
14 |
$116M |
$0 |
-$8.42M |
-$8.42M |
ARVN, RLYB, DICE, DCPH, EWTX
|
13F-HR |
8/10/2023, 04:06 PM |
Q1 2023 |
17 |
$121M |
$0 |
$0 |
|
ARVN, RLYB, DCPH, DICE, EWTX
|
13F-HR |
5/10/2023, 06:50 PM |
Q4 2022 |
17 |
$138M |
+$8.97M |
-$8.01M |
+$959K |
ARVN, RLYB, DCPH, EWTX, DICE
|
13F-HR |
2/6/2023, 04:12 PM |
Q3 2022 |
19 |
$165M |
$0 |
-$16.1M |
-$16.1M |
ARVN, RLYB, DCPH, EWTX, DICE
|
13F-HR |
11/10/2022, 04:35 PM |
Q2 2022 |
21 |
$154M |
+$5.15M |
-$3.24K |
+$5.15M |
ARVN, RLYB, DCPH, EWTX, SRRA
|
13F-HR |
8/9/2022, 04:31 PM |
Q1 2022 |
21 |
$203M |
$0 |
-$11M |
-$11M |
ARVN, RLYB, HARP, EWTX, DCPH
|
13F-HR |
5/6/2022, 04:39 PM |
Q4 2021 |
22 |
$276M |
$0 |
-$1.53M |
-$1.53M |
ARVN, HARP, EWTX, RLYB, PASG
|
13F-HR |
2/11/2022, 04:35 PM |
Q3 2021 |
22 |
$347M |
+$70.4M |
-$79.7M |
-$9.29M |
ARVN, DCPH, RLYB, EWTX, HARP
|
13F-HR |
11/12/2021, 04:56 PM |
Q2 2021 |
19 |
$220M |
$0 |
$0 |
|
ARVN, CMRX, APTX, ALEC, ARAV
|
13F-HR |
8/12/2021, 04:19 PM |
Q1 2021 |
18 |
$430M |
+$55.5M |
-$1.21M |
+$54.3M |
ARVN, HARP, DCPH, EWTX, PASG
|
Restatement |
8/12/2021, 04:16 PM |
Q4 2020 |
17 |
$433M |
+$5.5M |
-$5.47M |
+$27K |
ARVN, DCPH, PASG, HARP, APTX
|
13F-HR |
2/10/2021, 05:26 PM |
Q3 2020 |
18 |
$248M |
+$1.72M |
-$16M |
-$14.3M |
DCPH, ARVN, HARP, PASG, APTX
|
13F-HR |
11/12/2020, 05:01 PM |
Q2 2020 |
20 |
$349M |
$0 |
-$70.5M |
-$70.5M |
ARVN, DCPH, PASG, HARP, PRNB
|
13F-HR |
8/13/2020, 04:17 PM |
Q1 2020 |
20 |
$334M |
+$39.3M |
-$29.7M |
+$9.64M |
ARVN, DCPH, PASG, HARP, PRNB
|
13F-HR |
5/14/2020, 04:30 PM |
Q4 2019 |
19 |
$392M |
+$535K |
-$123M |
-$122M |
DCPH, ARVN, PRNB, HARP, ARAV
|
13F-HR |
2/12/2020, 05:35 PM |
Q3 2019 |
19 |
$331M |
+$3.07M |
-$59M |
-$55.9M |
DCPH, PRNB, ARVN, HARP, APTX
|
13F-HR |
11/14/2019, 04:16 PM |
Q2 2019 |
21 |
$373M |
+$10.9M |
-$7.7M |
+$3.25M |
DCPH, PRNB, ARVN, HARP, STIM
|
13F-HR |
8/13/2019, 04:26 PM |
Q1 2019 |
20 |
$365M |
+$45.4M |
-$39.3M |
+$6.08M |
DCPH, PRNB, ARVN, HARP, STIM
|
Restatement |
6/4/2019, 05:12 PM |
Q4 2018 |
20 |
$364M |
+$3.65M |
-$5.31M |
-$1.66M |
DCPH, PRNB, APTX, STIM, ARVN
|
13F-HR |
2/13/2019, 04:50 PM |
Q3 2018 |
20 |
$550M |
+$130M |
-$6.37M |
+$124M |
DCPH, APTX, PRNB, STIM, ARVN
|
13F-HR |
11/13/2018, 04:15 PM |
Q2 2018 |
15 |
$414M |
+$163M |
-$26.5M |
+$136M |
DCPH, APTX, STIM, CRSP, UMRX
|
13F-HR |
8/14/2018, 04:19 PM |
Q1 2018 |
14 |
$185M |
+$18.9M |
-$25.4M |
-$6.54M |
DCPH, CRSP, WVE, OBSVF, OXFD
|
13F-HR |
5/15/2018, 04:40 PM |
Q4 2017 |
16 |
$214M |
+$11.4M |
-$48M |
-$36.5M |
DCPH, EDGE, IRTC, WVE, CRSP
|
13F-HR |
2/14/2018, 05:20 PM |
Q3 2017 |
16 |
$215M |
+$81.7M |
-$5.85M |
+$75.8M |
DCPH, IRTC, EDGE, OXFD, WVE
|
13F-HR |
11/14/2017, 04:28 PM |
Q2 2017 |
15 |
$117M |
+$2.11M |
-$56.3M |
-$54.2M |
IRTC, EDGE, OXFD, WVE, CRSP
|
13F-HR |
8/14/2017, 04:36 PM |
Q1 2017 |
16 |
$195M |
+$73.6M |
-$23.7M |
+$49.9M |
IRTC, VSAR, EDGE, WVE, OXFD
|
13F-HR |
5/15/2017, 04:15 PM |
Q4 2016 |
15 |
$140M |
+$12.7M |
-$5.74M |
+$6.95M |
VSAR, EDGE, OXFD, WVE, CRSP
|
13F-HR |
2/14/2017, 04:28 PM |
Q3 2016 |
14 |
$139M |
+$1.79M |
-$3.78M |
-$1.99M |
WVE, VSAR, EDGE, OXFD, DMTX
|
13F-HR |
11/14/2016, 04:36 PM |
Q2 2016 |
14 |
$116M |
+$7.84M |
-$9.95M |
-$2.11M |
EDGE, VSAR, WVE, OXFD, DMTX
|
13F-HR |
8/15/2016, 04:47 PM |
Q1 2016 |
13 |
$110M |
+$7.83M |
-$7.17M |
+$667K |
EDGE, VSAR, DMTX, OXFD, WVE
|
13F-HR |
5/16/2016, 04:59 PM |
Q4 2015 |
10 |
$149M |
+$65M |
-$22.2M |
+$42.9M |
EDGE, VSAR, DMTX, ALDR, OXFD
|
13F-HR |
2/16/2016, 04:41 PM |
Q3 2015 |
13 |
$115M |
+$10.4M |
-$15.3M |
-$4.83M |
VSAR, ALDR, OXFD, DVAX, CMRX
|
13F-HR |
11/16/2015, 04:22 PM |
Q2 2015 |
14 |
$151M |
+$21.9M |
-$24.4M |
-$2.49M |
ALDR, VSAR, OXFD, CMRX, DVAX
|
13F-HR |
8/14/2015, 04:09 PM |
Q1 2015 |
13 |
$142M |
+$25.5M |
-$73.1M |
-$47.6M |
VSAR, RLYP, OXFD, ALDR, CMRX
|
13F-HR |
5/15/2015, 04:31 PM |
Q4 2014 |
13 |
$206M |
$0 |
$0 |
|
VSAR, RLYP, CMRX, OXFD, CALA
|
13F-HR |
2/17/2015, 10:56 AM |